Modalis Therapeutics

Modalis Therapeutics EPS

The Earnings per Share (EPS) of Modalis Therapeutics (4883.T) as of Nov 19, 2026 is -24.20 JPY. In the previous year, Earnings per Share (EPS) was -28.66 JPY — a change of -15.56% (higher).

EPS

-24.20JPY

YoY

-15.56%

Last updated:

Earnings per Share (EPS) of Modalis Therapeutics is 2025 -24.20 JPY. Earnings per Share (EPS) of Modalis Therapeutics was 2024 -28.66 JPY. It decreases by -15.56% higher compared to the previous year.

The Modalis Therapeutics EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2019
1.48 JPY
Jan 1, 2020
-15.72 JPY
Jan 1, 2021
-25.51 JPY
Jan 1, 2022
-92.59 JPY
Jan 1, 2023
-74.94 JPY
Jan 1, 2024
-28.66 JPY
Jan 1, 2025
-24.20 JPY
Jan 1, 2026 (e)
-22.20 JPY
The Modalis Therapeutics EPS history
YEAREPSYoY
est-22.20JPY-8.26%
-24.20JPY-15.56%
-28.66JPY-61.76%
-74.94JPY-19.06%
-92.59JPY+262.98%
-25.51JPY+62.23%
-15.72JPY-1,159.89%
1.48JPY-164.25%
-2.31JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Modalis Therapeutics Stock analysis

What does Modalis Therapeutics do? Modalis Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Modalis Therapeutics stock

Earnings per Share (EPS) of Modalis Therapeutics is -24.20 JPY in 2025.

Earnings per Share (EPS) of Modalis Therapeutics changed from -28.66 JPY to -24.20 JPY, representing a -15.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Modalis Therapeutics since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Modalis Therapeutics

All Key Metrics — Modalis Therapeutics